Global Biosensors Market Analysis–Trends, Insights and Forecasts (2021-2027)

  • Publish Date
    September 7, 2021
  • No of Pages
  • SKU Code
    GIR 8029
  • Format

Global Biosensors market – Overview

The report will cover the overall analysis and insights in relation to the size and growth rate of the “Global Biosensors market” by various segments at a global and regional level for the 2014-2027 period, with 2014-2019 as historical data, 2020 as a base year, 2021 as an estimated year and 2021-2027 as forecast period.

Global Biosensors Market – Introduction

Biosensors are medical devices that are primarily used to sense or detect the presence or concentration of biological substances, such as a biomolecule or a microorganism. They are analytical devices that can convert a biological response into an electrical signal. Biosensors majorly comprise three parts, including a component that identifies an analyte and produces signal, a signal transducer, and a reader device. Biosensors find their applications in food & beverages, environmental monitoring, home care diagnostics. and various nanomechanical biosensors. In addition, biosensor applications are also widely dominant in the field of plant biology to study metabolic processes.

Significant rise in chronic diseases such as diabetes across the globe, surge in biotechnology R&D, and increased demand for home care devices are the major factors that drive the biosensors market growth. In addition, considerable increase in preference of biosensors in glucose monitoring devices contributes to the market growth. However, high cost associated with these devices and lack of inclination toward adoption of new treatment devices are the major factors anticipated to hamper the market growth. On the contrary, technological advancements in biosensors to make them portable and easy to handle is anticipated to create lucrative opportunities in the future.


Global Biosensors Market Report Scope

  • The scope of the report covers the clear understanding and overview of the product.
  • Analysis of market trends in the region, with market data considering 2020 as the base year, 2021 as the estimate year and forecast for 2027 with projection of CAGR from 2021 to 2027.
  • The report covers discussion of economic trends and technology.
  • Market estimates represent revenue.
  • In-depth analysis of the market segmentation assists in determining the prevailing market scope.
Attribute Details
Market size available for years 2014–2027
Base year considered 2020
Forecast period 2021–2027
Historical period 2014-2019
Forecast units Value (USD) & Volume (Million Units)
Forecast units Value (USD) & Volume (Million Units)
Segmentation By Regions
North America, Europe, Asia Pacific, Latin America and Middle East & Africa
By Countries
United States, Russia, China, Germany, United Kingdom, France, Japan, Israel, Saudi Arabia, South Korea, United Arab Emirates, Canada, Indonesia, Malaysia, Switzerland, Australia, India, Italy, Sweden, Spain, Belgium, Netherlands, Norway, Brazil, Argentina, Mexico, South Africa and 54 Others.
By Type
Embedded Device and  Sensor Patch.
By Product
Wearable Biosensor and Non-Wearable Biosensor.
By Application
Point of Care, Home Diagnostics, Research Lab and Others.
By Technology
Electrochemical Biosensor, Optical Biosensor, Piezoelectric Biosensor, Thermal Biosensor, Nanomechanical Biosensor and Others.
Companies covered Abbott Point of Care Inc.; ABTECH Scientific Inc.; AgaMatrix Inc.; Anitoa Systems LLC; Binergy Scientific Inc.; Biolan Microbiosensores S.L.; Bio-Rad Laboratories Inc.; Cambridge Life Sciences Limited; F. Hoffmann-La Roche Ltd; GE Healthcare Life Sciences; I-SENS Inc.; LifeScan Inc.; Medtronic plc; MilliporeSigma; NeuroSky Inc.; Nova Biomedical Corporation; PerkinElmer Inc.; Sarissa Biomedical Ltd; Sensor-Kinesis Corporation and Others.

Segments Covered in Global Biosensors Market

  • The market is segmented on the basis of product, technology and region. Based on product, the global biosensors market is divided into wearable biosensors and nonwearable biosensors. Based on technology, the market is classified into electrochemical biosensors, optical biosensors, piezoelectric biosensors, thermal biosensors and nanomechanical biosensors. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Covid-19 Impact on the Global Biosensors Market

  • COVID-19 has not only affected humanity but also has brought economic devastation around the world. This pandemic’s effect on the global economy is expected to be far more intense than the global financial crisis between 2008 and 2009. It is affecting the demand and supply chain, which will severely hurt global trade. The supply chain is the key to fulfill customer demands. Due to COVID-19, several countries put on certain restrictions on imports and exports of non-essential goods. However, due to the effectiveuse of biosensors in collecting analytical information, there has been no restriction on the supply and distribution of biosensors across the globe.
  • Furthermore, due to partial and total lockdowns in different parts of the world, the demand for products has been hit in various industries. However, due to the time-saving and user-friendly nature of biosensors in collecting analytical information, their demand has increased drastically during the pandemic. Being an essential commodity greatly helped the market for biosensors evade the COVID-19 impact.
  • In the initial period, due to complete lockdown, many companies either halted their production or operated with fewer employees. Moreover, product demand decreased in the initial phase, which led to downsizing the number of employees or reducing wages.

 Recent Developments in Global Biosensors Market

  • In January 2021, Roche signed a Global Business Partnership Agreement (GBP) with Sysmex to deliver hematology testing solutions. The new agreement aims to utilize the IT systems to lead to improved clinical decision-making and customer experience. This successful, long-running partnership continues to evolve and bring hematology testing innovations to laboratories globally.
  • In December 2020, Abbott announced its next-generation, sensor-based glucose monitoring technology, FreeStyle Libre 2, which received approval by Health Canada for adults and children (4 years and older) with diabetes.
  • In December 2020, Bio-Rad Laboratories announced the expansion of its joint marketing agreement with Siemens Healthineers, in which Bio-Rad will provide quality control products and Unity Quality Control data management solutions for Siemens Healthineers’ Atellica Solution platforms.
  • In November 2020, Medtronic launched InPen integrated with real-time Guardian Connect CGM data. InPen is the first and only FDA-cleared smart insulin pen on the market for people on multiple daily injections (MDI).
  • In October 2020, Bio-Rad Laboratories announced the global launch of its CFX Opus 96 and CFX Opus 384 Real-time PCR Systems, along with, a cloud-based instrument connectivity, data management, and analysis platform.
  • In September 2020, Medtronic received US Food and Drug Administration (FDA) approval of its MiniMed 770G hybrid closed loop system. This newest insulin pump system offers the company’s most advanced SmartGuard technology, as featured in the MiniMed 670G system, with the added benefits of smartphone connectivity and an expanded age indication down to the age of 2 years old.
  • In June 2020, Abbott and Tandem Diabetes Care finalized an agreement to develop and commercialize integrated diabetes solutions that combine Abbott’s world-leading continuous glucose monitoring (CGM) technology with Tandem’s innovative insulin delivery systems to provide more options for people to manage their diabetes.

 Key Market Players in Global Biosensors Market

  • The major players in the Global Biosensors Market are Abbott Point of Care Inc.; ABTECH Scientific Inc.; AgaMatrix Inc.; Anitoa Systems LLC; Binergy Scientific Inc.; Biolan Microbiosensores S.L.; Bio-Rad Laboratories Inc.; Cambridge Life Sciences Limited; F. Hoffmann-La Roche Ltd; GE Healthcare Life Sciences; I-SENS Inc.; LifeScan Inc.; Medtronic plc; MilliporeSigma; NeuroSky Inc.; Nova Biomedical Corporation; PerkinElmer Inc.; Sarissa Biomedical Ltd; Sensor-Kinesis Corporation and others.
  • Also, the Global Biosensors Market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

Objectives of the Global Biosensors Market

  • To provide detailed information regarding drivers, restraints, opportunities and challenges are influencing the growth in the Global Biosensors Market.
  • To analyze the competitive intelligence of players based on company profiles and their key growth strategies.
  • To strategically analyze micro markets with respect to the individual growth trends, their prospects, and their contribution to the total Global Biosensors Market.
  • To analyze competitive developments such as expansions, and product launches, along with research & development (R&D) activities undertaken in the Global Biosensors Market.
  • A unique model is created customized for each study also offers suggestions that help enterprises to identify and mitigate risks.


  • Global Industry Reports will also support you post-purchase for a period of 6 months to answer any of your queries related to the following market and to provide you any more data if you need, for your analysis.
  • Also, you can buy some selected Chapters from the report.


Objectives Of The Study

Market Definition

Market Scope

Market Stakeholders

Market Limitations

Summary of changes in global biosensors market


Research data

Secondary data

Primary data

Global Biosensors Market Size Estimation

Global Biosensors Market Breakdown & Data Triangulation

Global Biosensors Market Share Analysis

Global Biosensors Market Risk assessment/limitations

Assessment Of The Impact Of Covid-19 On The Global Biosensors Market



Global Biosensors Market Introduction

Global Biosensors Market Dynamics

Global Biosensors Market Drivers

Emergence of nanotechnology-based biosensors

Significant technological advancements in last few years

Increasing use of biosensors to monitor glucose levels in individuals with diabetes

Surging demand for home-based point-of-care devices due to COVID-19 pandemic

Rising government initiatives toward diagnostics


Global Biosensors Market restraints

Slow rate of commercialization and reluctance in adopting new treatment practices

High costs involved in R&D

Global Biosensors Market Opportunities

Emerging market in developing countries

High-growth opportunities in food industry and environmental monitoring applications

High-growth opportunities in wearable device market

Global Biosensors Market Challenges

Government regulations—long certification and approval cycles

Pricing pressure in POC market

Porters Five Force Model

Moderate-to-high bargaining power of suppliers
Moderate-to-high threat of new entrants
Moderate threat of substitutes
High-to-moderate intensity of rivalry
Moderate bargaining power of buyers



Industry trends

Strategic benchmarking

Pricing analysis

Value chain analysis

Ecosystem analysis

Patent analysis

Trade analysis



Embedded Device

Sensor Patch


Wearable Biosensor

Non-Wearable Biosensor


Electrochemical Biosensor

Optical Biosensor



Thermal Biosensor

Nanomechanical Biosensor

And Others


Point of Care

Home Diagnostics

Research Lab

and Others



North America








Rest of Europe

Asia Pacific




Rest of Asia Pacific

Rest of the World

Latin America

Middle East & Africa



Footprint analysis of the top players in the global biosensors market

Product & service portfolio matrix

Market share analysis

Company evaluation quadrant

Company evaluation quadrant for start-ups/smes

Competitive scenario


(Business overview, Products & services offered, Recent Developments, Competitive analysis, SWOT Analysis,)

  1. Abbott Point of Care Inc.
  2. ABTECH Scientific Inc.
  3. AgaMatrix Inc.
  4. Anitoa Systems LLC
  5. Binergy Scientific Inc.
  6. Biolan Microbiosensores S.L.
  7. Bio-Rad Laboratories Inc.
  8. Cambridge Life Sciences Limited
  9. Hoffmann-La Roche Ltd
  10. GE Healthcare Life Sciences
  11. I-SENS Inc.; LifeScan Inc.
  12. Medtronic plc
  13. MilliporeSigma
  14. NeuroSky Inc.
  15. Nova Biomedical Corporation
  16. PerkinElmer Inc.
  17. Sarissa Biomedical Ltd
  18. Sensor-Kinesis Corporation
  19. 150 Others.


Discussion guide

Available customizations

Related reports


Research Methodology is the process used to collect information and data for the purpose of making business decisions. The success of a research project is entirely dependent on the research methodology adopted by the company. Research Methodology and Scope We have implemented a mix of primary and secondary research for our market estimate and forecast. Secondary research formed the initial phase of our study, where we conducted extensive data mining, referring to verified data sources such as independent studies, company annual reports, white papers, case studies, government and regulatory published articles, technical journals, magazines, and paid data sources. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

In the primary research process, various primary sources from both supply and demand sides have been interviewed to obtain qualitative and quantitative information important for respective regions. The primary sources from the supply side included industry experts such as CEOs, VPs, marketing directors, technology and innovation directors, and related executives from key companies and organizations operating in the respective regions. The primary data has been collected through questionnaires, e-mails, and telephonic interviews, end-user surveys, consumer surveys, technology distributors and wholesaler’s surveys.

  • Quantitative methods (e.g. surveys) are best for measuring, ranking, categorizing, identifying patterns and making generalizations
  • Qualitative methods (e.g. interviews) are best for describing, interpreting, contextualizing, and gaining in-depth insight into specific concepts or phenomena
  • Mixed methods allow for a combination of numerical measurement and in-depth exploration.

Market drivers and restraints, along with their current and expected impacts, technological scenario and expected developments, end-use industry trends and dynamics  and consumer behavior trends  these forecasting parameters were considered.

Ethical approach, attention to detail, consistency, latest trend in the market and highly authentic source these are benefits of company’s research methodology.

Global Industry Reports

Market size estimation methodology top-down and bottom-up approaches

Both top-down and bottom-up approaches have been used to estimate and validate the total size of the virtual reality market. These methods have also been extensively used to estimate the sizes of various market subsegments. Estimating the size of the market in each region by adding the sizes of country-wise markets and tracking the ongoing and upcoming implementation of virtual reality projects by various companies in each region and forecasting the size of the virtual reality market based on these developments and other critical parameters, including COVID-19 related impacts

Data Triangulation

After arriving at the overall market size—using the market size estimation processes explained above—the market has been split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures have been employed, wherever applicable. The data has been triangulated by studying various factors and trends from both the demand and supply sides. It provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, company profiles, key player strategies competitive developments and key developments) influencing the virtual reality market growth.

Statistical Model

Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis.

Frequently Asked Questions ?

The emergence of nanotechnology-based biosensors, significant technological advancements in the last few years, increasing use of biosensors to monitor glucose levels in individuals with diabetes, surging demand for home-based point of care devices due to the COVID-19 pandemic, and rising government initiatives toward diagnostics are driving the growth of the biosensors market.

The major players in the Global Biosensors Market are Abbott Point of Care Inc.; ABTECH Scientific Inc.; AgaMatrix Inc.; Anitoa Systems LLC; Binergy Scientific Inc.; Biolan Microbiosensores S.L.; Bio-Rad Laboratories Inc.; Cambridge Life Sciences Limited; F. Hoffmann-La Roche Ltd; GE Healthcare Life Sciences; I-SENS Inc.; LifeScan Inc.; Medtronic plc; MilliporeSigma; NeuroSky Inc.; Nova Biomedical Corporation; PerkinElmer Inc.; Sarissa Biomedical Ltd; Sensor-Kinesis Corporation and others.

North America holds the largest share in the global biosensor market followed by Europe and Asia Pacific, respectively.